What is iGii?
iGii operates at the intersection of nanotechnology and industrial application, specializing in the production of Gii, a pure, porous, 3D carbon nanostructure. This material possesses extraordinary physical and chemical properties, making it an ideal candidate for high-sensitivity sensor applications. By leveraging its unique structural characteristics, iGii is actively disrupting the point-of-care diagnostics market, providing a sustainable and efficient alternative to traditional sensing materials. The company's multidisciplinary team of scientists and engineers is dedicated to bridging the gap between laboratory-scale innovation and large-scale industrial deployment, positioning iGii as a key player in the next generation of deep tech solutions.
How much funding has iGii raised?
iGii has raised a total of $11.2M across 1 funding round:
Other Financing Round
$11.2M
Other Financing Round (2024): $11.2M with participation from Archangel Investors, Scottish National Investment Bank, and Par Equity
Key Investors in iGii
Scottish National Investment Bank
The Scottish National Investment Bank is a development investment bank established to provide long-term, patient capital investments for businesses, projects, and communities across Scotland. Its mission is to support the development of a fairer and more sustainable economy by encouraging both public and private capital investments.
Par Equity
Par Equity is a venture capital firm based in Edinburgh and Leeds, specializing in investing in innovative, high-growth technology companies from Seed to Series A. With a focus on deep tech and enterprise software, the company seeks to partner with exceptional teams to bring disruptive technologies to market.
Archangel Investors
Archangel Investors is a prominent business angel syndicate based in Scotland, focusing on early-stage technology and life sciences companies. They provide not only capital but also strategic mentorship to help high-potential startups scale their operations effectively.
What's next for iGii?
With the recent influx of capital, iGii is poised to scale its manufacturing capabilities to meet the rising demand for high-performance diagnostic sensors. The strategic focus will likely shift toward commercializing its Gii platform across broader industrial sectors, including environmental monitoring and advanced healthcare diagnostics. By leveraging the expertise of its institutional partners, the company aims to solidify its market position, optimize its supply chain, and drive long-term value through sustainable technological advancement. The path forward involves rigorous product validation and the expansion of its commercial partnerships to ensure that Gii becomes the industry standard for sensitive, sustainable sensing applications.
See full iGii company page
